Proxy filing
Logotype for Q32 Bio Inc

Q32 Bio (QTTB) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Q32 Bio Inc

Proxy filing summary

30 Apr, 2026

Voting matters and shareholder proposals

  • Election of Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos, Ph.D. as Class II directors to serve until the 2029 Annual Meeting or until a successor is elected or qualified.

  • Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Advisory vote to approve the compensation of named executive officers.

  • Provision to transact any other business properly brought before the Annual Meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends voting in favor of all director nominees and proposals.

  • Directors up for election are nominated for a term ending at the 2029 Annual Meeting.

Executive compensation and say-on-pay

  • Advisory, non-binding vote on the compensation of named executive officers is included as a proposal.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more